Shares of Ross Stores (ROST) spiked last week following a solid earnings report, which marked its 6th consecutive quarterly revenue and earnings beat. Shares declined a little over 1% on Friday, and I think shares look like a bargain. Like its peer TJX Companies (TJX), I believe the company is o
Valeant Pharmaceuticals (NYSE:VRX) shares are on a tear, and the company’s first-quarter financial results show that management is making headway in paying down debt. However, the business itself continues to sputter, and ultimately this rally could be short-lived if sales can’t find their footing.
The good news
Valeanthas been struggling to offset declining sales following....More>>>
Intrexon (XON) has made a small yet strategic acquisition in buying GenVec (GNVC); with the purchase, XON gets AdenoVerse, a platform of adenovirus vectors for delivering drugs and vaccines that dovetails nicely with its existing suite of gene therapy technologies, suggests John McCamant, editor of The Medical Technology Stock Letter.
The ability to increase the payloads of viral vectors....More>>>
Looking for a way to play the impending bounce in gold prices? You should be, and you should be looking at Nexus Gold Corp. (OTCMKTS:NXXGF, CVE:NXS) in particular. This junior gold miner is gelling at the exact right time, for all the right reasons.
First and foremost, gold prices are on the verge of bounce, largely driven by an impending pullback of the overextended U.S. dollar.
The market is clearly taking its lead from the buzz surrounding the tax reform vote as futures spent the overnight session on a dizzying roller coaster ride. This morning’s trade is less exciting with the major indices trading mixed; however, there are still a number of popular stocks that